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Recent years have witnessed a steep increase in studies on the diverse roles of neuronal cation-chloride co-
transporters (CCCs). The versatility of CCC gene transcription, posttranslational modification, and trafficking
are on par with what is known about ion channels. The cell-specific and subcellular expression patterns of
different CCC isoforms have a key role in modifying a neuron’s electrophysiological phenotype during devel-
opment, synaptic plasticity, and disease. While having a major role in controlling responses mediated by
GABAA and glycine receptors, CCCs also show close interactions with glutamatergic signaling. A cross-
talk among CCCs and trophic factors is important in short-term and long-termmodification of neuronal prop-
erties. CCCs appear to be multifunctional proteins that are also involved in shaping neuronal structure at
various stages of development, from stem cells to synaptogenesis. The rapidly expanding work on CCCs
promotes our understanding of fundamental mechanisms that control brain development and functions
under normal and pathophysiological conditions.Introduction
Ion trafficking across biological membranes is mediated by
channels and transporters, and these two types of molecules
form the basis of electrical signaling in the nervous system.
However, the volume of research on voltage- and ligand-gated
channels is orders of magnitude higher than what has been
devoted to the study of neuronal ion transporters. This bias
has no rational foundation: it does not reflect a difference in
the impact or versatility of their functions. What is often ignored
is that ion transporters are as important as channels in the gener-
ation of electrical signals.
During the recent years, there has been a sharp increase in the
interest of neurobiologists in plasmalemmal ion-transport mech-
anisms, especially in cation chloride cotransporters (CCCs).
Initially, CCCswere studied in nonneuronal cells in order to eluci-
date their role in volume regulation (Payne et al., 2003). More
recently, it has turned out that these transporters are crucial in
the control of the electrochemical Cl- gradient that is required
for ‘‘classical’’ hyperpolarizing postsynaptic inhibition mediated
byGABAA receptors (GABAARs) and glycine receptors (Figure 1).
The rapidly expanding research within this field has shown that
CCCs play a fundamental role in neuronal proliferation, differen-
tiation, disease, damage, and recovery, as well as in a variety of
phenomena traditionally associated with plasmalemmal
receptor- and channel-mediated effects, such as those involved
in synaptic plasticity. Different CCCs show distinct cellular and
subcellular expression patterns, and their functions are modu-
lated via short-term and long-term changes at the level of tran-
scription, translation, posttranslational modifications, and traf-
ficking. Furthermore, CCCs are involved in intricate signaling
cascades with growth factors and hormones. In view of their
functional versatility, CCCs are likely to gain importance in
drug research.820 Neuron 61, March 26, 2009 ª2009 Elsevier Inc.The milieu inte´rieur of the central nervous system (CNS) is
tightly regulated by the blood-brain barrier and other epithelial
structures, such as the choroid plexus, which involves a wide
spectrum of ion transporters, including CCCs (Pedersen et al.,
2006; Praetorius, 2007). These topics will not be discussed in
the present review, and, with our main focus on neuronal
CCCs, only some basic aspects of the ion-regulatory functions
of glial cells will be touched upon. Outside the nervous system,
CCCs are expressed in all organ systems, hence playing a key
role in, for instance, salt transport and the control of blood pres-
sure (Pedersen et al., 2006; Russell, 2000; Flatman, 2008). It is
important to recognize the wide spectrum of CCC functions in
experiments on transgenic animals and on drugs that affect
these ion transporters.
Structure and Molecular Diversity
The CCC family in mammals consists of nine members encoded
by the genes Slc12a1-9. The CCC proteins are glycoproteins
with apparent molecular weights of 120–200 kDa. Seven out of
the nine CCCs described so far are plasmalemmal ion trans-
porters (Gamba, 2005; Mercado et al., 2004; Payne et al.,
2003), and in terms of function they fall into three categories:
two members are Na-K-2Cl cotransporters (NKCCs; isoforms
NKCC1 and NKCC2), one is an Na-Cl cotransporter (NCC),
and four are K-Cl cotransporters (KCCs; isoforms KCC1-4).
The physiological roles of the remaining two CCCs (CIP1 or
Slc12a8, and CCC9 or Slc12a9) are yet unknown.
The predicted secondary structure of CCCs, confirmed only
for NKCC1 so far (Gerelsaikhan and Turner, 2000), consists of
12 membrane spanning segments that are flanked by intracel-
lular termini that constitute about half of the protein. Hetero-
and homo-oligomers of the different CCCs have been described
for nearly all CCCs (Blaesse et al., 2006; Pedersen et al., 2008;
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ReviewFigure 1. Ion-Transport Mechanisms Underlying GABAA and Glycine Receptor-Mediated Responses in Immature and Mature Neurons
(Left) NKCC1 mediates Cl– uptake in immature hippocampal and cortical neurons, while an as yet unidentified Cl– transporter denoted by X operates in some
neurons either in parallel with NKCC1 or in its absence. (Right) In mature CNS neurons, KCC2 is the principal K-Cl cotransporter, and it is often coexpressed
with KCC3. Cl– transport by all CCCs is fuelled by the Na+ and K+ gradients generated by the Na-K ATPase. Because the intracellular concentration of Cl– is
high in immature neurons (indicated by the shade of blue), EGABA and EGly are not directly affected by the intracellular HCO3
– concentration, while in mature
neurons, the channel-mediated net efflux of HCO3
– can have a major effect on the reversal potentials. For further details, see text.Simard et al., 2007; and references cited therein). However, the
available data are not conclusive regarding the mechanisms
whereby oligomerization affects CCC function.
With the exception of NKCC2 and NCC, which are predomi-
nantly found in kidney, all CCCs are expressed in neurons or glial
cells—or both—at least at some stage of CNS development.
KCC1 is considered a ‘‘household’’ isoform in various cell types,
including glial cells, but present data suggest little or no expres-
sion in central neurons (Kanaka et al., 2001; Li et al., 2002; Payne
et al., 1996; Rivera et al., 1999; Rust et al., 2007). In contrast,
KCC2 is an exceptional CCC, as it is exclusively expressed in
CNS neurons (Karadsheh and Delpire, 2001; Payne et al.,
1996; Uvarov et al., 2005; Williams et al., 1999). There has
been surprisingly little work on KCC3 despite its presence in
various brain regions (Becker et al., 2003; Boettger et al., 2003;
Le Rouzic et al., 2006; Pearson et al., 2001). Interestingly,
KCC3 protein levels show a developmental increase (Boettger
et al., 2003; Pearson et al., 2001) that is similar to the extensively
studied upregulation of KCC2, a topic to be discussed in detail
below. Even less is known about the possible role of KCC4 in
the nervous system, an isoform that is expressed at a high level
in the embryonic brain (Li et al., 2002). Another CCC that has at-
tracted considerable interest among neurobiologists is NKCC1
(Gamba, 2005; Payne et al., 2003).
Evolution of CCCs
Transporter proteins, such as CCCs, may have arisen by dupli-
cation of genes encoding channel-type protein subunits with
a smaller number of transmembrane segments (Saier, 2003).
The existence of putative CCC homologs in C. elegans and in
a cyanobacterium points to an early evolutionary origin of this
protein family (Xu et al., 1994). Consistent with this, homologs
of CCCs are present in diverse organisms. Many plant species
have a CCC gene that seems to encode for a functional bumeta-
nide-sensitive Na-K-2Cl cotransporter (Colmenero-Flores et al.,
2007). Given that Drosophila apparently has only one KCC gene,
and that its expression is neuron specific (Hekmat-Scafe et al.,
2006), it is tempting to speculate that the first KCC evolvedin animals with a nervous system to serve inhibitory neurotrans-
mission.
Alternative Splicing
Alternative splicing greatly increases the diversity of the pro-
teome. Alternative transcripts have often distinct expression
patterns, and they can be translated into proteins with different
structures, phosphorylation sites, or subcellular localizations.
With regard to CCCs expressed in the CNS, splice variants are
known for KCC1, KCC2, KCC3, and NKCC1 (Gamba, 2005; Mer-
cado et al., 2004; Uvarov et al., 2007). KCC3a is expressed in the
brain, whereas KCC3b is restricted to organs outside the CNS. In
the adult rat brain, alternative splicing of KCC3a has been re-
ported to create a neuron-specific KCC3c form, whereas the
native KCC3a is restricted to glia (Le Rouzic et al., 2006). Two
functional isoforms with distinct expression patterns were
described for NKCC1 (Randall et al., 1997; Vibat et al., 2001).
NKCC1a and NKCC1b are both expressed ubiquitously, but
the relative expression level for NKCC1b is higher in the adult
brain. The difference between NKCC1a and NKCC1b is an
NKCC1a-specific 16 amino acid peptide encoded by exon-21
that contains a putative PKA phosphorylation site. In three out
of four NKCC1 mutant mice described so far, both isoforms
are disrupted (Table 1). However, the mouse characterized by
Dixon et al. (1999) is an NKCC1a-specific knockout.
The mammalian KCC2 (Slc12a5) gene generates two iso-
forms, KCC2a and KCC2b, with different N termini (Uvarov
et al., 2007). The mRNA levels of the two isoforms are similar in
the neonatal mouse. While the overall expression of KCC2a
remains relatively constant during postnatal development, the
expression of KCC2b is strongly upregulated, especially in the
cortex (Uvarov et al., 2007). This indicates that KCC2b is respon-
sible for the extensively studied ‘‘developmental shift’’ from
depolarizing to hyperpolarizing GABAergic responses, a conclu-
sion supported by the finding that GABAergic responses
remain depolarizing in cortical cultures from knockout mice
(Zhu et al., 2005), which are now known to lack KCC2b only
(Uvarov et al., 2007).Neuron 61, March 26, 2009 ª2009 Elsevier Inc. 821
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ReviewTable 1. Major Phenotypes of Mice with Disruptions of Genes Encoding CCCs
Affected Isoforms Mice Described by Major Characteristics of Phenotype
KCC1 KCC1 knockout Rust et al., 2007 no obvious phenotype
KCC2 KCC2a and KCC2b knockout Hu¨bner et al., 2001b die after birth due to respiratory failure
KCC2b knockout Woo et al., 2002 survival up to P17; generalized seizures; low bodyweight
hypomorphic mice;17% of normal
KCC2 (KCC2a and KCC2b)
Tornberg et al., 2005 increased anxiety-like behavior; increased seizure
susceptibility; impaired spatial learning and memory;
reduced sensitivity to thermal and mechanical stimuli
KCC3 KCC3a-c knockout Howard et al., 2002;
Boettger et al., 2003
peripheral neuropathy; deafness (inner ear defects);
neurodegeneration; reduced seizure threshold;
hypertension (neurogenic mechanism; Rust et al., 2006)
KCC4 KCC4 knockout Boettger et al., 2002 deafness (inner ear defects); renal tubular acidosis
NKCC1 NKCC1a and NKCC1b knockout Delpire et al., 1999; Flagella et al.,
1999; Pace et al., 2000
deafness and imbalance (inner ear defects); impaired
blood pressure; growth retardation; defective
spermatogenesis; alterations in locomotion; increased
threshold to thermal stimulation
NKCC1a knockout Dixon et al., 1999 deafness and imbalance (inner ear defects)Analyzing the phenotypes of knockout mice has shed some
light on the physiological functions of the two KCC2 isoforms,
which have distinct functions in the brain (Uvarov et al., 2007).
Mice that completely lack KCC2 expression die immediately
after birth due to severe motor defects, including respiratory
failure (Hu¨bner et al., 2001b). In contrast, KCC2b-specific
knockout mice are viable, but show abnormal posture and gait
and frequent seizures within a couple of days after birth and
die at around 2 postnatal weeks, perhaps because of the recur-
rent seizures (Table 1; Woo et al., 2002). KCC2a is obviously
important for some basic functions of lower brain structures,
and it is sufficient to promote survival for up to 3 postnatal weeks,
but the absence of KCC2b leads to seizures during this period.
Most published data on the spatial and temporal expression
patterns of KCC2 reflect the expression of both KCC2a and
KCC2b, because themRNA probes and antibodies used in these
studies detect both isoforms. Hence, in most of what is dis-
cussed below, ‘‘KCC2’’ will refer to both splice variants.
Expression Patterns of CCCs
A wealth of data indicate that one of the major factors underlying
phenotypic variation among distinct types of neurons is based
on the cell-specific as well as subcellular patterns of CCC
expression.
Neuron-Specific Expression of KCC2
The expression of only a few genes is as tightly restricted to
central neurons as Slc12a5 (encoding KCC2). KCC2 mRNA is
abundant in most neurons of the mature CNS but shows negli-
gible expression in nonneuronal cell types, neuronal progenitors,
or peripheral neurons. The CNS neuron-specific expression of
KCC2 seems, at least in mammals, to be ensured by multiple,
redundant mechanisms, including binding sites for neuron-en-
riched transcription factors such as Egr4 and neuron-restrictive
silencing elements (Uvarov et al., 2005, 2006) (Figure 2).
KCC2 is located in the plasma membrane of somata and
dendrites in various brain regions, e.g., cerebellar granule cells
(Williams et al., 1999), thalamic relay cells (Bartho et al., 2004),
auditory brainstem neurons (Blaesse et al., 2006), and cortical822 Neuron 61, March 26, 2009 ª2009 Elsevier Inc.neurons (Gulyas et al., 2001; Szabadics et al., 2006). Freund
and coworkers demonstrated high levels of KCC2 in the
dendritic spines of rat cortical pyramidal neurons and interneu-
rons (Gulyas et al., 2001), a puzzling observation in light of the
preferential localization of glutamatergic synapses to spines
and GABAergic synapses to somata and dendritic shafts.
However, this paradox is at least partly resolved by a recent
study that demonstrated a morphogenic role of KCC2 in spine
formation independent of its role in ion transport (Li et al.,
2007; see below).
In immature neurons in the auditory brainstem, KCC2 is initially
expressed at a high level in a functionally inactive form, and the
neurons generate depolarizing GABAA and glycine responses
due to the presence of an unidentified Cl– uptake transporter (de-
noted as ‘‘X’’ in Figure 1; Balakrishnan et al., 2003; Blaesse et al.,
2006). Functionally inactive KCC2 has also been observed in
primary cortical cultures during the first few days in vitro (Khirug
et al., 2005). These results imply that the available data support-
ing a key role of NKCC1 in Cl– uptake in immature neocortical
and hippocampal neurons cannot be directly extrapolated to
other types of neurons; and further, the mere presence of
KCC2 protein in a neuron does not necessarily imply that it is
functionally active.
Expression Patterns of NKCC1
Because of inconsistent and contradictory results, general state-
ments about developmental changes or about the cellular and
subcellular distribution of NKCC1 in CNS neurons are hardly
possible. Even the widespread idea that neuronal NKCC1
expression decreases during postnatal rodent development
(Hu¨bner et al., 2001a; Yamada et al., 2004) is challenged by
data that show a developmental increase in the NKCC1 mRNA
and protein levels (Clayton et al., 1998; Mikawa et al., 2002;
Wang et al., 2002; Yan et al., 2001a). A paper by Delpire and
coworkers (Plotkin et al., 1997), often cited as evidence for
a postnatal downregulation of NKCC1 in the rat forebrain, actu-
ally demonstrates roughly similar levels at P0 and P21. As
described below, NKCC1 is functional in a wide variety of both
juvenile and mature central neurons.
Neuron
ReviewFigure 2. Regulation of CCC Functionality
CCC functions are regulated by transcriptional control, alternative splicing, subcellular targeting, and posttranslational modifications that lead to cell-specific as
well as discrete subcellular expression patterns of the distinct CCC proteins. (Upper left) An example of transcriptional control for KCC2. Neuron-enriched tran-
scription factors (e.g., Egr4) and NRSEs are responsible for the neuron-specific expression of KCC2 and regulate the expression level (Uvarov et al., 2005, 2006).
(Upper right panel) Alternative splicing of KCC2 and NKCC1 where the various splice variants have distinct binding sites for kinases such as SPAK/OSR and PKA
(Randall et al., 1997; Uvarov et al., 2007). (Lower left) An example of subcellular targeting of NKCC1 into the axon (axon initial segment; Khirug et al., 2008) and of
KCC2 into the dendritic shafts and spines. The mechanisms whereby various CCCs are targeted into axons versus dendrites and somata are not known. While
protein 4.1N is involved in the anchoring of spine KCC2 (Li et al., 2007), it is not clear whether this is true for KCC2 located in dendritic shafts and neuronal somata
(indicated by a question mark). (Lower right) Expression levels of plasmalemmal functional CCCs are influenced, among other things, by the rate of insertion from
secretory (exocytic) vesicles and removal by endocytic vesicles. The illustration shows how kinases can modify CCC function by influencing the relative rates of
endo- and exocytosis. In this specific example, the KCC2 endocytosis is suppressed by a PKC-mediated phosphorylation of KCC2 (Lee et al., 2007). The scheme
also highlights the lack of evidence (indicated by a question mark) for direct modulation of the intrinsic rate of ion transport by neuronal CCCs.An essential role of NKCC1 in cell proliferation has been
proposed in many studies (for review, see Russell, 2000). The
high expression of NKCC1 in embryonic ventricular zones (Hu¨b-
ner et al., 2001a; Li et al., 2002; but see Clayton et al., 1998)
points to a role in neuronal proliferation. NKCC1 is also ex-
pressed in the inner ear, where a lack of this protein leads to
a defect in the production of endolymph and hence to deafness
that is not neuronal in origin (Delpire et al., 1999; Dixon et al.,
1999). Similar effects have been observed in KCC3 and KCC4
knockout mice (Boettger et al., 2002, 2003). NKCC1 is also ex-
pressed in dorsal root ganglion (DRG) cells (Rocha-Gonzalez
et al., 2008) and in olfactory receptor neurons (Kaneko et al.,
2004; Reisert et al., 2005).
Much of the published data on NKCC1 protein expression in
CNS neurons has been obtained using amonoclonal NKCC anti-
body, T4 (Lytle et al., 1995). While T4 is a useful tool in immuno-
blots (Lytle et al., 1995; Zhang et al., 2006), interpretation ofthese data are complicated by NKCC1 expression in both
neurons and glia (Kanaka et al., 2001; Hu¨bner et al., 2001a).
Further, perhaps because of differences in the methods of
epitope retrieval, there are conflicting data on T4’s capability to
reliably detect NKCC1 immunohistochemically (Chen et al.,
2005; Dixon et al., 1999; Li et al., 2008; Zhang et al., 2006,
2007). An antibody generated by Forbush and coworkers
detects the phosphorylated NKCC1, thereby providing data on
both the presence and functional state of NKCC1 (Flemmer
et al., 2002). In the absence of reliable immunohistochemical
techniques, other methods, including specific pharmacological
block with bumetanide and analysis of NKCC1 knockout mice,
have been used to examine the expression patterns of functional
NKCC1 (Khirug et al., 2008).
Coexpression of KCC2 and NKCC1
There are no data that would suggest K-Cl cotransport in axons
and no evidence for the presence of axonal KCC2 protein (e.g.,Neuron 61, March 26, 2009 ª2009 Elsevier Inc. 823
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ReviewHu¨bner et al., 2001b; Szabadics et al., 2006). The terminals of
retinal ON bipolar neurons have been reported to contain
KCC2 (Vardi et al., 2000), but it is perhaps not appropriate to
call these neurites ‘‘axons,’’ as they do not generate action
potentials. In contrast to this, functional evidence indicates
that NKCC1 is expressed in axons (e.g., Jang et al., 2001; Khirug
et al., 2008; see below). The mechanisms that underlie the differ-
ential subcellular targeting of distinct CCCs to the axonal and
somatodendritic compartments are not known, but recent
evidence from work on NKCC1 in epithelial cells suggests that
alternative splicing can play a major role (Carmosino et al.,
2008). The coexpression of NKCC1 and KCC2 in specific
neurons that is evident on the basis of structural and functional
data (e.g., Duebel et al., 2006; Gavrikov et al., 2003; Khirug
et al., 2008; Martina et al., 2001; Marty and Llano, 2005;
Romo-Parra et al., 2008; Szabadics et al., 2006; Trevino and Gu-
tierrez, 2005; Vardi et al., 2000) indicates a tight control of [Cl–]i
that can result in the generation of intraneuronal Cl– gradients
(Figure 2; and below).
KCC3 and KCC4 Expression Patterns
There is not much data on the neuronal expression patterns of
KCC3 and KCC4, but what is available clearly indicates that
further work on these two isoforms is highly motivated. In immu-
noblots, KCC3 was detected in all adult CNS regions, and KCC3
immunoreactivity was mainly located in myelinated tracts of the
spinal cord and brain, although cells in the choroid plexus, pyra-
midal neurons in the hippocampus and cortex, and cerebellar
Purkinje cells were also labeled (Pearson et al., 2001). In
contrast, two other studies failed to observe significant KCC3
expression in the CNS white matter in adult mice (Boettger
et al., 2003; Howard et al., 2002). KCC3 seems, however, to be
expressed by the Schwann cells in peripheral nerves of juvenile
mice (Byun and Delpire, 2007). KCC4 mRNA is highly expressed
in the ventricular zone during embryonic development (Li et al.,
2002), and in adult brain tissue it has been detected in the supra-
chiasmatic nucleus (Le Rouzic et al., 2006).
Basic Properties and Modes of Operation of CCCs
With regard to their source of energy, ion transporters fall into
two categories: primary active transporters are directly fueled
by ATP, while secondary active transporters take the energy
for transport of the driven ion from the electrochemical gradient
of another ion species. The ubiquitous primary active trans-
porter, the Na-K ATPase, generates plasmalemmal K+ and Na+
gradients that provide the main source of energy for most
secondary active transporters, including all CCCs (Figure 1).
Extrusion of Cl– via KCC-mediated K-Cl cotransport is driven
by the K+ gradient, while uptake of Cl– in many (but not all;
e.g., Balakrishnan et al., 2003; Zhang et al., 2007) neurons is
driven by NKCC1 that exploits the plasmalemmal Na+ gradient
as its energy source for Na-K-2Cl cotransport. The KCC2 co-
transporter operates at near-equilibrium (Payne et al., 2003),
which permits maximization of the efficiency of harvesting
energy from the K+ gradient to fuel the extrusion of Cl–. The trans-
port stoichiometry of CCCs renders them electrically silent, thus
they do not directly influence the neuronal membrane potential.
Yet it should be noted that electroneutrality as such does not
provide any information on the possible presence or absence824 Neuron 61, March 26, 2009 ª2009 Elsevier Inc.of effects of membrane voltage on the transport process (see
Kaila, 1994).
The electroneutrality of CCCs is an obvious obstacle in elec-
trophysiological work on CCCs, precluding direct monitoring of
their function. Therefore, electrophysiological experiments on
CCCs exploit anion-permeable channels (mainly GABAA and
glycine receptors) as ‘‘read-out devices,’’ either by monitoring
the reversal potential of the channel-mediated currents or using
more sophisticated Cl– loading techniques that will be described
below. Additional techniques for analyzing ion transport by
CCCs are based on assays of 86Rb fluxes in cultured cells
(Payne, 1997) and on the use of Cl–-sensitive indicators (Ber-
glund et al., 2006; Verkman, 1990).
NKCC1 can be selectively blocked by a diuretic compound,
bumetanide (1–10 mM), which has an up to 500-fold higher
affinity for NKCC1 (Ki 0.1 mM) than for KCC2 (Payne et al.,
2003). Furosemide, another diuretic, blocks both NKCC1 and
KCCs with an equal potency, and it is often used at 100 mM or
higher to inhibit KCC2 in experiments on neuronal cultures and
slices. 100 mMdoes not provide a full block, and an obvious con-
founding factor is the simultaneous effect on NKCC1. In addition,
furosemide has inhibitory effects on N-methyl D-aspartate
(NMDA) and GABAA receptors (Staley, 2002). Dihydroindenyl-
oxy-alkanoic acid (DIOA) is yet another nonspecific drug that
has been extensively used to block K-Cl cotransport (Payne
et al., 2003). The lack of drugs with a specific action on KCC2
(and KCCs in general) has been a major problem in experimental
work on neuronal CCCs. However, in a recent high-throughput
screening study based on 234,000 compounds, a number of
molecules that inhibit KCC2 with little effect on NKCC1 were
identified (Delpire et al., 2009). Notably, an effective block of
KCCs is achieved (sometimes on purpose but often unintention-
ally) in electrophysiological experiments based on whole-cell or
gramicidin perforated-patch clamp recordings by replacing
intracellular K+ with Cs+, a standard procedure to obtain a better
space clamp. Cs+ blocks KCCs because the cation selectivity
sequence of K-Cl cotransport is K+ z Rb+ z NH4
+ >> Cs+
(Payne et al., 2003; Williams and Payne, 2004).
Neuronal Volume Regulation
In the brain, cell swelling and the concomitant decrease in the
interstitial space can lead to pathophysiological activity as well
as to ischemia due to the compression of blood vessels. While
cellular swelling induced by hypotonia (as often used in experi-
ments on nonneuronal cells) causes a net influx of water and
thereby leads to a fall in [Cl–]i, neuronal swelling is usually
brought about by intense synaptic activity and a concomitant
massive channel-mediated net influx of cations and Cl– that
drives an osmotically obliged net influx of water. Hence, the
mechanisms of swelling and KCC-mediated recovery are radi-
cally distinct under these two conditions. In case of neuronal
swelling, recovery can be based on two distinct mechanisms:
a genuine volume sensor that is able to kinetically activate K-Cl
cotransport, and/or an enhanced driving force for K-Cl cotrans-
port due to elevated intraneuronal Cl–. Interestingly, neurons are
thought to be devoid of water channels (aquaporins; Amiry-Mog-
haddam and Ottersen, 2003), which lowers their sensitivity to
osmotic challenges. Consistent with a role for KCC3 in neuronal
volume regulation, recovery of cell volume after hypotonic
Neuron
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knockout mice (Boettger et al., 2003). In contrast, KCC2’s role
in neuronal volume regulation is probably secondary to the steep
dependence of its net Cl– extrusion on the momentary intracel-
lular chloride load. Nevertheless, this does not exclude an addi-
tional regulatory role for KCC2 in response to an osmotic chal-
lenge (Bergeron et al., 2006).
Setting ECl and EGABA-A
One of the main tasks of CCCs is to maintain a constant [Cl–]i in
the face of channel-mediated fluxes that tend to dissipate the
transmembrane electrochemical Cl– gradient, i.e., the driving
force of GABAAR-mediated Cl
– currents. [Cl–]i is also affected
by chloride-dependent secondary active ion transporters
involved in neuronal HCO3
–/pH regulation (Chesler, 2003;
Hentschke et al., 2006; Romero et al., 2004). The sodium-inde-
pendent Cl/HCO3 exchanger AE3 may act as a significant Cl
–
uptake mechanism in neurons (Gonzalez-Islas et al., 2008),
and in some neurons might represent transporter X in Figure 1.
In addition to its role in neuronal Cl– homeostasis, HCO3
– acts
as a significant carrier of depolarizing current across GABAARs
(Kaila and Voipio, 1987). This is because neuronal pH regulation
leads to a much higher intracellular level of HCO3
– than would be
expected on the basis of a passive distribution. Hence, the
reversal potential of GABAA receptor-mediated responses
(EGABA-A) is not identical to the equilibrium potential of Cl
– (ECl),
but shows a deviation to more positive values (Kaila and Voipio,
1987). The bicarbonate-mediated current component can be
larger than the one mediated by Cl– in adult mammalian neurons
(Gulledge and Stuart, 2003; Kaila et al., 1993). Notably, the
reversal potential of the potassium-selective channels activated
by GABAB receptors (EGABA-B) would be identical to EGABA-A if (1)
K-Cl cotransport were at equilibrium (see below) and (2) GABAA
receptors were not permeable to bicarbonate. This is clearly not
the case, and EGABA-B attains values that are significantly more
negative than EGABA-A (Farrant and Kaila, 2007; Kaila, 1994).
Functional Regulation of CCCs
Thermodynamics versus Kinetics
Thermodynamics can be used when examining the energetic
conditions that are a prerequisite for a change in a system from
state A to state B, but the physical mechanisms and the time
course of this change play no role in this context. The energetic
conditions required for transmembrane ion movements to occur
can be derived from thermodynamics, which allows, for example,
calculating Nernstian ionic equilibrium potentials (in the case of
channel-mediated movements) as well as the equilibrium condi-
tions foragiven ion transporter. Itshouldbeemphasizedthata ther-
modynamic analysisdoesnot tell anything about transport kinetics
(the temporal, dynamic aspects of ion movements). Hence, even
a steep, energetically favorable ion gradient does not ‘‘activate’’
an ion transporter. In a manner analogous to a closed ion channel,
an ion transporter may be fully inactive despite the presence of
a strong energetic driving force of its substrate ions. The kinetics
of transport is determined by the number of functional plasmalem-
mal transporters as well as their intrinsic transport rates.
Equilibrium Conditions for KCCs and NKCCs
The reversal potential of a current mediated by an ion channel
defines the electrochemical equilibrium for the current: despitea free pathway provided by open channels for electrodiffusion,
no net movement of ions takes place. In an analogous manner,
an ion transporter is at thermodynamic equilibrium when no
net flux of ions is mediated by the transporter even if it is fully
activated. Under equlibrium conditions, ion fluxes do take place,
but the net influx and efflux of any given ion species are exactly
equal.
For KCCs, the equilibrium is defined by ½K+ o½Clo =
½K+ i½Cli. This simple equation has important consequences.
First, it implies that EK = ECl, which means that EGABA-A and
EGABA-B would be equal under KCC equilibrium if GABAARs
and the channels activated by GABABRs were ideally selective
for Cl– and K+, respectively. Second, it shows that when KCCs
are active, [Cl–]i is highly sensitive to changes in [K
+]o, and
a modest increase in [K+]o will lead to net uptake of Cl
– by
KCC2. Finally, it also implies that the driving force for extrusion
of Cl– by KCCs is enhanced during an elevation of [Cl–]i, and
therefore KCCsmay also contribute to extracellular K+ transients
(Voipio and Kaila, 2000). While it is worth re-emphasizing that
thermodynamic considerations as such are not sufficient to
make predictions about changes in the magnitude of ion trans-
port in response to an increase in the deviation from equilibrium
(i.e., the driving force acting on the transporter), we used the
somewhat fuzzy term ‘‘thermodynamic regulation’’ (Payne
et al., 2003) to define a situation where net fluxes mediated by
a close-to-equilibrium transporter such as KCC2 are directly
affected by the driving forces of the substrate ions. However,
even KCC2 appears not to be constitutively active under all
conditions, and an increasing amount of evidence indicates
that kinetic regulation plays a crucial role.
The equilibrium of NKCCs is defined by ½Na+ o½K+ o½Cl2o =
½Na+ i½K+ i½Cl2i . The second power of [Cl–]i looks intriguing,
and at first sight onemight think that slight changes in [Cl–]i might
exert an effect on NKCC1 via ‘‘thermodynamic regulation.’’
However, under physiological conditions, NKCC1 is not close
to equilibrium (Russell, 2000), but rather it is controlled by kinetic
regulatory mechanisms that include a [Cl–]i-sensitive step (see
below). For instance, in mammalian DRG neurons, kinetic
constraints inactivate Cl– uptake by NKCC1 even in the presence
of a substantial thermodynamic driving force (Rocha-Gonzalez
et al., 2008).
The Plasmalemmal Na-K ATPase
It is immediately clear from the close functional relationship
between the plasmalemmal Na-K ATPase and CCCs (see
Figure 1) that any factor that has an effect on the Na-K ATPase
will have an influence on the operation of CCCs. This means
that endogenous ligands (e.g., endogenous ouabains and agrin)
that regulate neuronal Na-K ATPase isoforms will also affect
CCC functions (Hilgenberg et al., 2006). Moreover, manipula-
tions that lead to altered KCC or NKCC function may in fact
reflect a change in Na-K ATPase function. For instance, when
examining changes in CCC function following neuronal stimula-
tion, the tight coupling between Na-K ATPases, CCCs, and
EGABA-A should be kept in mind. Interestingly, structural interac-
tions have been demonstrated between the Na-K ATPase and
KCC2 via coimmunoprecipitation of the a2 subunit and KCC2
in synaptic membrane fractions (Ikeda et al., 2004). Furthermore,
the brain-type creatine kinase, an enzyme involved in theNeuron 61, March 26, 2009 ª2009 Elsevier Inc. 825
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via a protein-protein interaction (Inoue et al., 2006; Salin-Cante-
grel et al., 2008).
Kinetic Regulation of CCCs
As pointed out before, the ion-translocating capacity of CCCs
cannot be directly monitored using electrophysiological tech-
niques, and there are no data available on the transport capacity
of any CCC at the molecular level. Furthermore, except for a few
cases, published data on the kinetic activation or inactivation of
a given neuronal CCC do not provide information on whether this
reflects a change in the number of membrane-located trans-
porters, a change in their intrinsic rates of ion transport, or
both (Figure 2). In the following, ‘‘kinetics’’ and ‘‘kinetic regula-
tion’’ are terms that lump together the membrane trafficking of
the CCCs as well as the (putative) changes in their unitary rates
of ion transport.
Phosphorylation mechanisms play a pivotal role in the kinetic
regulation of CCCs. In pioneering studies, it was shown that
phosphorylation activates NKCC1 (Lytle and Forbush, 1992). A
fall in [Cl–]i below a homeostatic ‘‘set point’’ promoted direct
phosphorylation and activation of NKCC1, leading to an active
uptake of Cl– (Russell, 2000). In contrast, the conventional view
is that phosphorylation inactivates KCCs (Payne et al., 2003).
However, there is evidence that tyrosine phosphorylation leads
to activation of KCC2 (Vale et al., 2005; Wake et al., 2007; but
see Stein et al., 2004) and that KCC2 is also directly phosphory-
lated and thereby activated by the protein kinase C (PKC; Lee
et al., 2007; Banke and Gegelashvili, 2008). The activation by
PKC is probably due to increased surface stability of the phos-
phorylated protein (Lee et al., 2007). In addition to PKC, several
other kinases can regulate CCCs (Delpire and Gagnon, 2008;
Kahle et al., 2008b). The serine-threonine kinases Wnks and
SPAK/OSR1 are of particular interest in that they seem to be co-
regulators of NKCCs and KCCs. Studies with NKCCs in non-
neuronal cells suggest that chloride-sensitive Wnks phosphory-
late and activate the SPAK/OSR1, which in turn phosphorylates
and activates NKCCs. While KCC2a and KCC3a contain
a SPAK-binding motif, KCC2b and KCC3b do not, and the bio-
logical significance of this difference remains unknown. Most
of the work above has been done in nonneuronal cells, and for
neurobiologists, a crucial question is which of thesemechanisms
are relevant for CNS function.
CCCs and the Polarity of GABAA Receptor-Mediated
Responses
Chloride Extrusion and Hyperpolarizing
GABA Responses
The pioneering work on the role of K-Cl cotransport in conven-
tional hyperpolarizing GABAergic transmission was done in
crayfish preparations (Aickin et al., 1982) and mammalian
cortical neurons (Misgeld et al., 1986; Thompson and Ga¨hwiler,
1989). In neurons, EK is more negative than the resting Vm, which
allows K-Cl cotransport to support conventional hyperpolarizing
IPSPs (recall that when KCC is close to equilibrium, ECl is close to
EK). However, the HCO3
– permeability of GABAARs implies that
EGABA-A > ECl, and hence active Cl
– extrusion is a necessary
but not a sufficient condition for hyperpolarizing GABAA
responses (Kaila et al., 1993; Kaila, 1994; Rivera et al., 1999).826 Neuron 61, March 26, 2009 ª2009 Elsevier Inc.Inmost central neurons studied so far, themain chloride extruder
is KCC2, but in someneuronsKCC3 appears to have a significant
role in setting EGABA-A (Boettger et al., 2003).
Chloride Uptake and Depolarizing GABA Responses
NKCC1 appears to be the main Cl– uptake mechanism respon-
sible for GABA-mediated depolarizing currents mediated by
postsynaptic and extrasynaptic receptors in developing hippo-
campal and neocortical neurons (Achilles et al., 2007; Sipila¨
et al., 2006; Yamada et al., 2004). A prominent exception from
the conventional hyperpolarizing or slightly depolarizing
responses evoked by GABA in mature cortical neurons was
reported by Szabadics et al. (2006; but see Glickfeld et al.,
2009). They showed that the GABA-mediated postsynaptic
potentials evoked by chandelier cells (a class of interneurons
that exclusively target the axon initial segment of principal
neurons) had a depolarizing driving force of 15 mV. The under-
lying Cl– uptake mechanism was identified as NKCC1 in subse-
quent work, which showed that the GABA-mediated depolariza-
tion in the axon initial segment was abolished by bumetanide and
in NKCC1 knockout mice (Khirug et al., 2008). The role of NKCC1
in neuronal Cl– uptake is not restricted to cortical structures. For
instance, in olfactory receptor neurons, a drastic reduction in the
driving force of the depolarizing odor-activated Cl– current
occurs in the presence of bumetanide and in NKCC1 knockout
mice (Reisert et al., 2005; see also Kaneko et al., 2004). In
contrast, the bumetanide-insensitive transporter(s) accounting
for depolarizing GABA and glycine actions in the immature audi-
tory brainstem and retinal ganglion and amacrine cells have not
been identified (Balakrishnan et al., 2003; Zhang et al., 2007).
Depolarizing actions by GABAA and glycine receptors have
also been observed in presynaptic terminals. A classical
example is the primary afferent depolarization (PAD) in DRG
neurons (Rudomin and Schmidt, 1999; Russell, 2000), which
seems to be largely but not fully attributable to Cl– uptake medi-
ated by NKCC1 (Rocha-Gonzalez et al., 2008). However, all of
the available data are based on measurements carried out in
the cell body, which may not be representative of other cellular
compartments, and it will be critical to obtain an estimate of
[Cl–]i in the central terminals of primary afferent fibers. Within
the CNS, Cl– uptake has been shown to produce depolarizing
presynaptic GABA or glycine responses with a consequent
increase in glutamate release in the ventromedial hypothalamus
(Jang et al., 2001), the calyx of Held (Price and Trussell, 2006),
terminals on isolated hippocampal CA3 neurons (Jang et al.,
2006), and parallel fibers in the cerebellum (Stell et al., 2007).
In these studies, presynaptic NKCC1-mediated Cl– accumula-
tion was evident in the hypothalamus, but not in the calyx of
Held.
Intraneuronal Cl– Gradients
NKCC1 and KCCs are coexpressed in certain types of mature
neurons, and spatially distinct expression patterns can result in
steady-state chloride gradients and compartmentalization of
EGABA-A within an individual neuron (e.g., Duebel et al., 2006;
Gavrikov et al., 2003; Khirug et al., 2008; Price and Trussell,
2006; Szabadics et al., 2006). The steady-stateEGABA-A gradients
can be surprisingly large; in cortical principal neurons, the axo-
somato-dendritic Cl– gradient attains a value up to 15–20 mV
(Khirug et al., 2008; Szabadics et al., 2006). A similar gradient
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ular bushy cells in the auditory brainstem (Price and Trussell,
2006). Given that distinct GABAergic interneurons in various
brain structures target anatomically distinct sites in the postsyn-
aptic neurons (Freund and Buzsaki, 1996), it is not correct to
assign a singularEGABA-A value to a given neuron—amore appro-
priate approach is to specify the EGABA-A level of a given
GABAergic input in the postsynaptic neuron.
Assessing the Efficacy of Neuronal Cl– Extrusion
The gramicidin-perforated patch clamp technique is often
thought to be an ideal electrophysiological technique to study
the presence and efficacy of neuronal Cl– extrusion. Because
the gramicidin-induced pores are not permeable to Cl–, there is
no flux of Cl– between the recording pipette and the intracellular
compartment (Kyrozis and Reichling, 1995). A novel approach
where the cell membrane is kept intact relies on measuring
EGABA-A on the basis of the reversal potentials of single GABAA
and NMDA receptor channels (Tyzio et al., 2006, 2008).
However, even if an ideal technique were available, measuring
EGABA-A in a resting neuron can at best verify the presence of
Cl– extrusion, but this provides no information on the efficacy
of Cl– transport. Even a very inefficient Cl– extrusion mechanism
will be able to maintain a hyperpolarizing EGABA-A if the net Cl
–
influx into a neuron (i.e., the cellular Cl– load) is small. Momentary
changes in a target neuron’s ionic load are among the most
important context-dependent variables that influence
GABAergic signaling (Buzsaki et al., 2007; Farrant and Kaila,
2007). Hence, in order to gain information that is physiologically
more relevant than an estimate of the steady-state EGABA-A in
a resting neuron, it is important to design experiments to enable
an assessment of the efficacy of Cl– extrusion. Quantitative
assessments of the efficacy of Cl– extrusion are based on
a procedure where a defined Cl– load is imposed on a cell, and
the cell’s capability tomaintain the [Cl–]i provides a valid estimate
of the efficacy of extrusion (e.g., Jarolimek et al., 1999; Khirug
et al., 2005; Rivera et al., 2002). Ion-loading techniques have
been routinely used in the study of neuronal pH regulation (Ches-
ler, 2003), but the resting steady-state value of intraneuronal pH
does not provide an idea of the efficacy of acid extrusion. By
analogy, EGABA-A is not a reliable indicator of a neuron’s capacity
to regulate its [Cl–]i, as was nicely illustrated in a recent study on
chronically injured cortex, which showed that a marked
decrease in KCC2 function was not associated with a detectable
change in EGABA-A (Jin et al., 2005).
The ‘‘Developmental Shift’’ in GABAA
Receptor-Mediated Signaling
It is frequently stated in both reviews and primary research
papers that ‘‘during the neonatal period,’’ KCC2 is upregulated,
leading to a negative shift in EGABA-A from depolarizing to hyper-
polarizing. This is a misleading generalization from work on
rodent hippocampal and cortical pyramidal neurons, and there
are pronounced species-specific differences in the temporal
expression patterns of KCC2 within a given neuronal population.
At the time of birth, ‘‘altricial’’ species such as rats show delayed
KCC2 expression in the hippocampus and neocortex, while in
the guinea pig (a species with precocious neonates) KCC2
expression has already reached a high level (Rivera et al.,1999). This is also true for the perinatal human hippocampus
and neocortex (Vanhatalo et al., 2005; but see Dzhala et al.,
2005), and a very early onset of KCC2 expression is seen in
the cortical subplate (Bayatti et al., 2008). On the other hand,
within a single species, high levels of KCC2 expression are first
seen in the spinal cord and subcortical brain regions, and there-
after in the cortex (Li et al., 2002; Rivera et al., 1999; Vinay and
Jean-Xavier, 2008; see also Blaesse et al., 2006). The novel
data on KCC2 isoforms (Uvarov et al., 2007) indicate that
KCC2b is responsible for the developmental increase in neuronal
Cl– extrusion, at least in the cortex and in the auditory brainstem
(Balakrishnan et al., 2003; Zhu et al., 2005). Interestingly, the shift
from GABAA receptor depolarization to hyperpolarization of
gonadotropin-releasing hormone neurons is delayed until the
time of puberty (Clarkson and Herbison, 2006).
A relatively high [Cl–]i is the ‘‘default’’ state of a wide variety of
fully differentiated nonneuronal mammalian cells (Pedersen
et al., 2006; Russell, 2000). Neurobiologists tend to regard imma-
ture neurons with their high [Cl–]i and rather depolarized EGABA-A
as something exceptional while, in fact, it is the mature central
neurons with their low [Cl–]i that are the ‘‘aberrant’’ ones. [Cl
–]i
in immature CNS neurons is typically in the range of 25–40 mM
(e.g., Achilles et al., 2007; Balakrishnan et al., 2003; Kakazu
et al., 1999; Kilb et al., 2002; Rohrbough and Spitzer, 1996; Sipila¨
et al., 2006; Yamada et al., 2004) and values typically of 5 mM
are seen in neuronal somata or dendrites after maturation (e.g.,
Khirug et al., 2008; Tyzio et al., 2008).
Inhibitory and Excitatory Actions of GABA
Unfortunately, the current literature on the developmental shift of
EGABA-A and its consequences is burdened by a major miscon-
ception: it is often assumed that depolarizing GABA actions
imply excitation and that a necessary and sufficient condition
for a genuinely inhibitory GABA action is an EGABA-A that is
more negative than resting Vm. This idea is a misleading simpli-
fication, which emphasizes the role of voltage inhibition (the hy-
perpolarizing response associated to an inhibitory postsynaptic
potential) and ignores the crucial role played by shunting inhibi-
tion (based on the conductance of postsynaptic GABAARs).
Shunting inhibition acts by decreasing the temporal and spatial
summation of excitatory inputs. Hence, several points should
be kept in mind when considering the relationships between
the steady-state values of EGABA-A and the efficacy of inhibition.
The opening of GABAARs will have a shunting inhibitory action
regardless of the value of EGABA-A. Moderately depolarizing
GABA actions can be functionally inhibitory and sometimes
even more effective than hyperpolarizing responses because
of the intrinsic outward rectification of GABAA currents and
because depolarization leads to the inactivation of Na+ channels
and activation of K+ channels. Finally, GABAergic transmission is
not necessarily excitatory even if the postsynaptic response
would be more positive than spiking threshold. This is because
the spike voltage threshold is not a fixed parameter, but depends
on the rate of change of the membrane potential, and also on the
background conductance (e.g., Katz, 1966).
In conclusion, the steady-state levels of EGABA-A do not give
a reliable estimate of the physiologically relevant efficacy of
postsynaptic inhibition. This does not, of course, imply that Cl–
transport is irrelevant here. It is important to recognize thatNeuron 61, March 26, 2009 ª2009 Elsevier Inc. 827
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brane potential, and fast changes take place in the driving
force of the GABAAR current as well as in the momentary Cl
–
load a neuron experiences. Hence, functional inhibition is largely
determined by the efficacy of Cl– extrusion, which has to be high
enough to maintain a level of EGABA-A sufficiently negative (but
not necessarily hyperpolarizing) to prevent the cell from firing.
In view of the large number of variables described above, it is
not surprising that GABA can have ‘‘dual’’ actions in developing
neurons (Khalilov et al., 1999; Lamsa et al., 2000). The duration of
the depolarizing postsynaptic potential outlasts the local
conductance increase, i.e., the ‘‘shunt.’’ Hence, depolarizing
GABAergic responses can facilitate the triggering of action
potentials by glutamatergic neurons (Gao et al., 1998). This
mode of action is consistent with a facilitatory or ‘‘permissive’’
role for depolarizing GABAergic transmission in the generation
of early network events (see Sipila¨ et al., 2005; Zheng et al.,
2006; and below). In an elegant study on neonatal rodent moto-
neurons, Jean-Xavier et al. (2007) first showed that depolarizing
IPSPs (dIPSPs) were able to facilitate spike triggering by
subthreshold excitatory events in their late phase. Notably, the
window of facilitation became wider as ECl was more depolar-
ized, and started earlier when the site of dIPSP generation was
moved away from the excitatory input. Therefore, in addition to
EGABA-A/EGly, the neuronal and synaptic architecture as well as
the temporal relationships among GABA/glycinergic and gluta-
matergic postsynaptic events are critical factors that control
the qualitative postsynaptic effects of depolarizing GABA/
glycinergic transmission. In summary, the widely spread idea
that a dichotomous ‘‘depolarizing-to-hyperpolarizing switch’’
would control the inhibitory or excitatory nature of GABA/
glycinergic transmission in developing circuits is a profound
oversimplification.
The Developmental Shift in EGABA-A
A large shift of EGABA-A from depolarizing to more negative and
often hyperpolarizing values appears to be a ubiquitous feature
of central neurons. A pioneering electrophysiological study on
this topic was carried out by Obata et al. (1978) in chick spinal
motor neurons, and the first observations related to the molec-
ular mechanisms of the shift were made by Rivera et al. (1999),
who showed that upregulation of KCC2 renders GABA hyperpo-
larizing in rat CA1 hippocampal neurons. The key observation
was an increase in KCC2 expression during the first 2 postnatal
weeks, a time window that was known to be associated with
a negative shift in EGABA-A. Because there are no selective drugs
to block CCCs in an isoform-specific manner, gene knockdown
experiments were done to confirm the role of KCC2.
In various regions of the brain, the appearance of hyperpolariz-
ing GABAAR signaling occurs earlier in the female and has
been attributed to higher KCC2 and/or lower NKCC1 activity
(Galanopoulou, 2008; Perrot-Sinal et al., 2007). The sex-specific
GABAergic responses appear to promote sexual differentiation
of the brain (Auger et al., 2001; Galanopoulou, 2008). In a recent
study on rat pup hippocampi, Tyzio et al. (2006) reported that
maternal oxytocin induces a perinatal hyperpolarizing shift in
EGABA-A to astonishingly negative values (100 mV and beyond).
The authors suggested that oxytocin blocks NKCC1, thereby
protecting the newborn brain from anoxic-ischemic damage,828 Neuron 61, March 26, 2009 ª2009 Elsevier Inc.a condition that is a major cause of neurological dysfunctions
in humans. However, the implications of these findings for the
human condition call for further studies.
Neuronal Maturation and Emerging Networks
Depolarizing GABA and the Generation of Endogenous
Activity in Developing Networks
There is a wide consensus that endogenous activity generated
prior to the maturation of sensory inputs plays a crucial role in
the development of neuronal networks (Ben-Ari et al., 2007;
Katz and Shatz, 1996; O’Donovan, 1999; Spitzer, 2006). Accord-
ing to a rather widespread and simplistic view, this kind of early
activity is directly driven by depolarizing GABAergic transmis-
sion, and the ‘‘depolarization-hyperpolarization switch’’ puts an
end to it. Notably, Minlebaev et al. (2007) have shown that in
the neonatal neocortex in vivo, blockingGABAergic transmission
has little effect on the basic patterns of the generation of sponta-
neous events known as ‘‘spindle bursts’’ (Khazipov et al., 2004).
In contrast, the dominating pattern of neocortical spontaneous
activity in vitro, which is reminiscent of hippocampal sharp
potentials, is sensitive to GABAA receptor antagonists (Rheims
et al., 2008). This type of activity, originally termed ‘‘giant depo-
larizing potentials’’ (GDPs), has been studied in detail in the
developing hippocampus, and there are two hypotheses
regarding the roles of depolarizing GABA in their generation. In
the scenario proposed by Ben-Ari and coworkers (Ben-Ari
et al., 2007), GABAergic interneurons are mainly responsible
for pacing GDPs in a phasic manner (Ben-Ari et al., 1989). While
all hippocampal regions are able to produce GDP-like activity,
the CA3 region shows the highest propensity for GDP genera-
tion. Concerning the role of depolarizing GABA, a more recent
view is that the GDPs are primarily paced by the CA3 glutamater-
gic pyramidal neurons, and depolarizing GABAergic signaling
(both synaptic and tonic) has a facilitatory role in their generation
(Sipila¨ et al., 2005). In other words, depolarizing GABAergic
transmission is temporally nonpatterned and has a permissive
or facilitatory role, while the intrinsic bursting properties of the
CA3 glutamatergic neurons are responsible for the temporal
patterning of GDPs. An analogous mechanism has recently
been proposed for starburst cells in the developing retina (Zheng
et al., 2006). Notably, GDPs are blocked by bumetanide both
in vitro and in vivo, pointing to a crucial role for NKCC1 (Dzhala
et al., 2005; Sipila¨ et al., 2006).
Crosstalk among Neurotrophic Mechanisms, CCCs,
and GABAergic Signaling
The concerted actions of CCCs and GABAergic signaling in
brain development comprise an extremely wide spectrum of
phenomena, and these will of course manifest themselves in
neuronal network function and behavior. In fact, GABA’s role in
the formation of neuronal connectivity starts already during the
early stages of neurogenesis (Owens and Kriegstein, 2002).
Moreover, GABAergic transmission plays a key role during ‘‘crit-
ical’’ periods, when the nervous system is particularly prone to
both normal and aberrant types of input (Hensch, 2005; Kanold
and Shatz, 2006).
GABAARs are functional in neuronal precursors and immature
neurons, long before the formation of GABAergic synapses (De-
marque et al., 2002; LoTurco et al., 1995; Owens et al., 1999).
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synaptic GABAergic signaling promotes action potential activity,
opening of voltage-gated Ca2+ channels, and activation of
NMDA receptors (Ben-Ari et al., 2007; Fukuda et al., 1998; Hen-
nou et al., 2002; Kandler and Gillespie, 2005; Serafini et al.,
1995). These responses lead to transient elevations of intracel-
lular Ca2+ levels and activation of downstream intracellular
signaling cascades, which are central in mediating the trophic
effects of GABA during development (Ben-Ari et al., 2007;
Owens and Kriegstein, 2002). Trophic effects of GABA have
been observed in vitro at various levels of neuronal and network
development, including DNA synthesis, migration, morpholog-
ical maturation of individual neurons, and synaptogenesis (Aker-
man and Cline, 2006; Liu et al., 2005, 2006; LoTurco et al., 1995;
Marty et al., 1996, 2000; Owens and Kriegstein, 2002; Represa
and Ben Ari, 2005; Reynolds et al., 2008; Simat et al., 2007;
Wang and Kriegstein, 2008; see also Andang et al., 2008). Inter-
estingly, the developmental patterns of GABAergic signaling are
repeated during adult neurogenesis in the dentate gyrus in vivo
(Esposito et al., 2005; Ge et al., 2006; Laplagne et al., 2007; To-
zuka et al., 2005; see also Toni et al., 2008). BDNF has been
ascribed a key role in a number of the studies cited above. It is
a well-known fact that the release of trophic factors is enhanced
during synchronous neuronal activity (Lessmann et al., 2003),
and one of the functions of the early spontaneous network
events described above may be to promote the release of these
substances.
Despite the above findings related to depolarizing GABA
actions, their significance in normal neuronal development
in vivo is not clear (Wang and Kriegstein, 2009). Somewhat
surprisingly, synaptogenesis and early brain development are
hardly affected in knockout mice where GABA synthesis, vesic-
ular transport, or vesicular release are eliminated (Jin et al., 1999;
Varoqueaux et al., 2002; Verhage et al., 2000; Wojcik et al.,
2006). On the other hand, using in utero electroporation to over-
express KCC2 in proliferating neurons, Cancedda et al. (2007)
found that while neuronal migration was not affected (but see
Heck et al., 2007), morphological maturation was markedly
impaired in immature neurons that were devoid of depolarizing
GABAergic responses.
An intriguing hypothesis suggests that presynaptically
released GABA acts as a self-limiting trophic factor in a negative
feedback loop where depolarizing postsynaptic GABAAR
responses are required for the developmental upregulation of
KCC2 (Ganguly et al., 2001; see also Leitch et al., 2005).
However, subsequent studies showed that developmental
KCC2 upregulation can take place in hippocampal and midbrain
cultures in the complete absence of GABAAR signaling (Ludwig
et al., 2003; Titz et al., 2003). Furthermore, during embryonic
development in VIAAT knockout mice, KCC2 mRNA and protein
levels are unaffected, despite the absence of GABAergic
synaptic transmission (Wojcik et al., 2006).
Role of CCCs in the Formation of Synapses
Depolarizing actions of GABA play at least a permissive role in
excitatory and inhibitory synaptogenesis (Akerman and Cline,
2007). In the Xenopus tadpole visual system in vivo, early overex-
pression of KCC2 led to a reduction in neuronal [Cl–]i levels, inter-
fering with the maturation of the glutamatergic system andenhancing the development of GABAergic synapses (Akerman
and Cline, 2006). Overexpression of KCC2 in early hippocampal
cultures selectively increased thenumberofGABAergicsynapses
and the frequency of GABAergic miniature postsynaptic currents
(Chudotvorova et al., 2005). Consistent with the above work,
Riekki et al. (2008) found that miniature IPSC frequency is lower
in mice with reduced KCC2 levels (Tornberg et al., 2005).
However, the various roles of CCCs in neuronal development
and connectivity may cover a much wider scope than what is
caused by their actions on GABAergic and glycinergic
responses. Recently, Li et al. (2007) obtained evidence that
KCC2may play amorphogenic role in the formation of excitatory
synapses during cortical development. Cultured KCC2/
neurons were found to have long, morphologically aberrant ‘‘filo-
podia-like’’ spines, but this phenotype could be rescued by
transfecting the neurons with an N-terminal deletion construct
that is not capable of mediating K-Cl cotransport. This sug-
gested that the role of KCC2 in spine maturation is not based
on its transport activity, but might be mediated by interactions
with cytoskeletal proteins. KCC2 immunoprecipitation assays
from adult mouse brain homogenate suggest an interaction
between the KCC2 C-terminal domain and the 4.1N protein,
which is known to mediate structural interactions between the
cytoskeleton, transmembrane proteins, and adhesionmolecules
(Denker and Barber, 2002). While it remains to be verified
whether KCC2 has a role in spine formation in vivo, neurons
from mice with reduced KCC2 protein levels show an increase
in the length of dendritic protrusions (Tornberg et al., 2005).
Thus, KCC2 may function as a synchronizing factor in the devel-
opment of inhibitory and excitatory neurotransmission. In this
scenario, the progressive developmental increase in the number
of functional glutamatergic synapses that target spines will be
paralleled by an increase in the KCC2-dependent neuronal Cl–
extrusion capacity, and consequently, by an increase in the
efficacy of GABAergic inhibition (Li et al., 2007).
Neuronal Plasticity
Postsynaptic GABAA signaling has the unique property of ‘‘ionic
plasticity,’’ which is based on short- and long-term changes in
the transmembrane anion gradients. A robust manifestation of
short-term GABAergic plasticity is apparent in CA1 pyramidal
neurons following high-frequency stimulation of Shaffer collat-
erals, a classical experimental paradigm to evoke long-term
potentiation. Under these conditions, the membrane potential
of CA1 pyramidal neurons shows a biphasic response, with
a prompt hyperpolarization followed by a large and prolonged
depolarization. The depolarizing phase of this GABAergic
response is attributable to two mechanisms: an initial and fast
positive shift in EGABA-A, caused by a bicarbonate-dependent
uptake of Cl– (see Kaila and Voipio, 1987) that partly overlaps
with and is followed by an increase in [K+]o, which has a direct
depolarizing action on the neuronal membrane potential (Fiumelli
and Woodin, 2007; Kaila et al., 1997; Voipio and Kaila, 2000).
Hence, pronounced short-term changes that affect the efficacy
and sometimes even the qualitative (inhibitory versus excitatory)
action of GABAergic transmission can take place in an activity-
dependent manner without the involvement of changes in the
kinetic modulation, trafficking and/or expression of CCCs.Neuron 61, March 26, 2009 ª2009 Elsevier Inc. 829
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turnover (recycling) at the plasmalemma (Lee et al., 2007), which
suggests that the transporter is subject to continuous kinetic
modulation. Recent work has shown that coincident firing of
pre- and postsynaptic neurons or prolonged postsynaptic
spiking alone can result in positive shifts in EGABA-A (Woodin
et al., 2003; Fiumelli et al., 2005). These shifts are dependent
on intracellular Ca2+, and a PKC-dependent mechanism was
suggested to mediate the functional downregulation of KCC2
(Fiumelli et al., 2005). This conclusion contradicts Lee et al.
(2007), who reported that PKC inhibits the endocytosis of
KCC2, resulting in functional upregulation of KCC2, and it has
been recently suggested (Brumback and Staley, 2008) that
changes in Na-K ATPase activity are responsible for the
activity-induced changes in EGABA-A that were observed by Fiu-
melli and coworkers.
In hippocampal slices exposed to a Mg2+-free solution, the
ensuing interictal activity was shown to downregulate KCC2
mRNA and protein in a BDNF-dependent manner, and it was
concluded that this pathophysiological plasticity is attributable
to transcriptional changes in KCC2 expression levels (Rivera
et al., 2004). However, the authors could not exclude the possi-
bility that the decreased efficacy of Cl– extrusion was caused by
changes in posttranscriptional mechanisms. Indeed, there is
evidence that BDNF can act on KCC2 function within a time
window that is too brief to be mediated by transcriptional effects
(Wardle and Poo, 2003). Hence, the overall picture looks rather
similar to what is known about the plasticity of glutamatergic
transmission: fast changes are mediated by posttranscriptional
mechanisms, but at the same time changes in gene expression
take place which appear to ‘‘consolidate’’ the initial effects.
Disease Mechanisms
Mutations of CCCs
While a large number of genetic defects in ion channels (channe-
lopathies) are known to produce severe dysfunctions of neuronal
signaling in diseases such as epilepsy, migraine, and pain (Mul-
ley et al., 2003; Waxman, 2007), little data are available for ion
transporters. However, a striking example of a genetic ‘‘trans-
porteropathy’’ is provided by hereditary motor and sensory
neuropathy with agenesis of the corpus callosum (HMSN/ACC;
Salin-Cantegrel et al., 2008), an autosomal recessive disease
characterized by progressive sensory neuropathy, mental retar-
dation, and dysmorphic features such as a high arched palate
and agenesis of the corpus callosum. All of the four identified
mutations that underlie this disease involve C-terminal deletion
of KCC3, which renders the transporter nonfunctional (Howard
et al., 2002). The mutations disrupt activation of KCC3 by the
brain-type creatine kinase, which suggests the first protein-
protein interaction involved in HMSN/ACC pathophysiology
(Salin-Cantegrel et al., 2008). KCC3 knockout mice have a
phenotype that is largely consistent with the human disease
(Boettger et al., 2003; Delpire and Mount, 2002; Howard et al.,
2002).
A substantial fraction of idiopathic epilepsies are thought to
have a polygenic basis (Mulley et al., 2005). Here, it is of interest
that kazachoc mutations of Drosophila kcc that reduce the level
of kcc protein are susceptible to epileptic-like seizures (Hekmat-830 Neuron 61, March 26, 2009 ª2009 Elsevier Inc.Scafe et al., 2006). However, no mutations or polymorphisms in
human CCC genes related to seizure susceptibility have been
published so far.
Neuronal Trauma
The brain is highly susceptible to a wide spectrum of acute and
chronic pathophysiological conditions, including anoxic-
ischemic states, mechanical damage, and epileptic activity. A
depolarizing shift in EGABA-A in response to neuronal trauma
has been observed following anoxia/ischemia, neurite transec-
tion, and osmotic imbalance (Katchman et al., 1994; Pond
et al., 2006; van den Pol et al., 1996). The trauma-induced effects
on EGABA-A are largely attributable to a downregulation of KCC2
with a consequent increase in [Cl–]i (Bonislawski et al., 2007;
Fukuda et al., 1998; Nabekura et al., 2002; Papp et al., 2008),
and some data point to a concurrent functional upregulation of
NKCC1 (Pond et al., 2006; Yan et al., 2001b). There is no doubt
that fast changes in CCC gene expression can take place in
response to neuronal trauma (De Koninck, 2007; Rivera et al.,
2002; Shulga et al., 2008), but the precise roles of transcriptional,
posttranscriptional, and posttranslational mechanisms in the
pathophysiological effects mediated by CCCs on [Cl–]i and
EGABA-A remain to be identified (see Figure 2).
Epilepsy
While the large majority (70%) of epilepsies is idiopathic, the
remaining cases are largely attributable to cerebrovascular
diseases, traumatic brain injury, and tumors. A downregulation
of KCC2 associated with epileptiform activity has been observed
in a number of in vivo and in vitro studies in animal models (Jin
et al., 2005; Pathak et al., 2007; Rivera et al., 2002, 2004), and
this mechanism may act as one of the links between neuronal
injury and epilepsy (Pathak et al., 2007). In a pivotal study, Miles
and coworkers showed that hippocampal slices obtained from
temporal lobe epilepsy patients generated interictal activity
that was attributable to depolarizing GABAA-mediated transmis-
sion in a subpopulation of principal neurons (Cohen et al., 2002;
see also Kohling et al., 1998). A follow-up study showed that the
depolarization was related to a downregulation of KCC2 and
that, interestingly, the interictal activity was blocked by bumeta-
nide (Huberfeld et al., 2007; see also Munoz et al., 2007). The
molecular cascades that lead to KCC2 downregulation in various
pathophysiological states include those mediated by BDNF-
TrkB signaling (Rivera et al., 2004).
GABAA-mediated transmission is not suppressed in epileptic
tissue (Avoli et al., 2005; Kohling et al., 1998), but the Cl– extru-
sion capacity seems to play a key role in setting the susceptibility
of neurons to epileptiform activity. In transgenic mice, the
propensity to epilepsy in vivo and hyperexcitability in vitro are
enhanced with an inverse relationship to the level of KCC2
expression (Riekki et al., 2008; Tornberg et al., 2005; Woo
et al., 2002; Zhu et al., 2005). GABAergic inhibition can also
revert into excitation without any change in the functional
expression of KCCs, as mentioned above (Kaila et al., 1997).
Indeed, epileptic seizures are associated with large extracellular
K+ transients, which may have a substantial GABAergic compo-
nent (Avoli et al., 2005; Kaila et al., 1997). A pathophysiological
increase in [K+]o can lead to a vicious circle that involves a further
depolarization of both the membrane potential and EGABA-A (Ka-
kazu et al., 2000; Payne et al., 2003; Thompson and Ga¨hwiler,
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signaling (Haglund and Hochman, 2005).
CCC Blockers as Putative Anticonvulsant Drugs
A number of studies have examined the possible utility of diuretic
drugs, especially furosemide and bumetanide, in the treatment
of epileptic disorders. While some observations indicate an anti-
convulsant action (e.g., Haglund and Hochman, 2005; Hochman
et al., 1995), the interpretation is complicated by the wide diver-
sity of the drugs’ cellular targets within and outside the brain and,
in the case of furosemide, because of its lack of specificity at the
molecular level (Staley, 2002). The search for novel drugs is
particularly important in the case of neonatal seizures, where
standard anticonvulsants have poor efficacy (Rennie and Boy-
lan, 2007). At the moment, bumetanide has attracted much
attention as a putative drug to suppress seizures in human
neonates (Dzhala et al., 2005, 2008; Kahle et al., 2008a), an
idea that is largely based on the assumption that seizure suscep-
tibility is linked to depolarizing actions of GABA in the neonate
brain (e.g., Ben Ari and Holmes, 2006). However, the expression
patterns of KCC2 and the parallel developmental characteristics
of the human EEG do not suggest that GABA would be overtly
depolarizing in fullterm newborn cortex (Vanhatalo et al., 2005),
but the situation is probably different for preterm neonates
(Dzhala et al., 2005; Vanhatalo et al., 2005). In addition, work
in vitro has resulted in conflicting data regarding the anticonvul-
sant properties of bumetanide (Kilb et al., 2007). Clearly, much
more research is needed to test the hypothesis of a connection
from nonpathophysiological depolarizing actions of GABA
to seizure generation in neonates and its possible clinical
implications.
Neuropathic Pain
Neuropathic pain is a common and highly debilitating condition
resulting from damage or dysfunction of peripheral nerves.
This type of pain is often refractory to standard analgesic agents,
and opioid treatment can result in unacceptable side effects.
Symptomatic management of neuropathic pain by suppressing
neuronal activity with antiepileptic drugs can also have undesir-
able side effects (Blackburn-Munro and Erichsen, 2005; Jensen,
2002; Rogawski and Loscher, 2004). Hence, neuropathic pain
represents a major unmet medical need. GABA and glycinergic
inhibition play a pivotal role via modulatation of the afferent input
into nociceptive neurons in the superficial dorsal horn and
control of their output to higher areas of the central nervous
system (Price et al., 2005). Loss of inhibitory neurotransmission
may underlie several forms of chronic pain. De Koninck and
coworkers have proposed that suppression of inhibition by
a collapse of the chloride gradient in dorsal horn lamina I neurons
is a cellular substrate of neuropathic pain (Coull et al., 2003;
De Koninck, 2007). They reported that peripheral nerve injury
decreased KCC2 expression and produced a depolarizing shift
in EGABA-A in a subpopulation of lamina I neurons in rats. This
loss of inhibition appeared to be mediated via BDNF released
from activated spinal microglia (Coull et al., 2005).
Pathogenic versus Protective Mechanisms
At first sight, downregulation of neuronal Cl– extrusion and
a consequent decrease in the efficacy of inhibition appears to
be maladaptive for the survival of diseased neuronal tissue.
Here, one should note that the responses of neurons to traumacan be causally related to the pathophysiological sequelae per
se, or to intrinsic protective mechanisms that promote neuronal
survival and re-establishment of functional connectivity (Payne
et al., 2003). It has been proposed that the posttraumatic down-
regulation of neuronal Cl– extrusion and the consequent depola-
rizing shift in EGABA-A are aspects of dedifferentiation of neurons
and neuronal networks that are permissive for the ‘‘recapitula-
tion’’ of developmental programs for the rewiring of surviving
neurons (Payne et al., 2003; Pieraut et al., 2007; Shulga et al.,
2008). Furthermore, in view of the tight link between the Na-K
ATPase and CCC functions, it is interesting that seizure activity
and neuronal damage have been shown to lead to a downregula-
tion of the sodium pump (e.g., Pylova et al., 1989; Ross and Sol-
tesz, 2000), which may well be a neuroprotective response to
minimize local oxygen and glucose demand during trauma-
related hyperexcitability and plasticity.
Conclusions and Topics for Future Work
Neurons typically have exceedingly complex morphological
properties, and the data reviewed above suggest that many
have steady-state intracellular Cl– gradients that are set by
cell-type-specific, subcellular expression patterns of functional
CCCs. An immediate question that arises here is the role of
such gradients in neuronal signaling during ongoing activity
(e.g., oscillations) in the brain. Spatial ‘‘sign changes’’ (inhibitory
versus excitatory) in GABAergic signaling have been identified
under steady-state conditions, for instance in mature neurons
in the retina (Gavrikov et al., 2003). Hence, it is possible that
the spectrum of context-dependent actions of GABA include
analogous sign changes that take place within a timescale of
perhaps tens of milliseconds, thereby adding a further degree
of freedom to the computational properties of neurons. Testing
this hypothesis will require fast and reliable monitoring of
neuronal membrane potential in parallel with measurements of
[Cl–]i, a task that can be achieved only after further developments
of Cl– imaging techniques.
It is likely that in vivo at least some functional CCCs are homo-
oligomers (Blaesse et al., 2006; Casula et al., 2001), and work
in vitro shows that monomers of distinct CCC isoforms can
combine to hetero-oligomers (Simard et al., 2007). But does
hetero-oligomerization also take place in vivo? And if it does,
what are the subunit compositions of native CCC hetero-oligo-
mers? Information of this kind is physiologically important, and
it will have immediate consequences onwork aimed at designing
drugs (such as antiepileptic or analgesic compounds) that target
CCCs in the living organism. Obtaining insight into CCC molec-
ular structure should help in solving these problems. Future
studies on polymorphisms will add to the spectrum of both func-
tional and dysfunctional CCCs, a topic that hasmuch potential in
the search for novel disease genes.
Current data also demonstrate that the CCCs are not only
working as Cl– transporters. This is in line with a number of
previous observations showing that plasmalemmal channels
and ion transporters are often multifunctional and that they can
exert actions at the level of cellular structure (Denker and Barber,
2002). The role that KCC2 has on spine formation may well be
a facet in a much broader picture where CCCs act as morpho-
genic factors. Little is known about the anchoring of CCCs,Neuron 61, March 26, 2009 ª2009 Elsevier Inc. 831
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tions that influence the functional and structural roles of CCCs. In
addition to the search for ion-regulatory metabolons incorpo-
rating CCCs, an intriguing question is whether ‘‘plasticity’’ of
anchoring proteins is a determinant of subcellular CCC expres-
sion and functionality.
In addition to the electrophysiologically obvious link between
CCCs and anion-permeable channels gated by GABA and
glycine, CCCs are involved in intricate, bidirectional interactions
with trophic factors as well as intracellular signaling cascades.
However, we are still at a loss regarding the precise mechanisms
whereby, and to what extent, trophic factors control CCC
expression and functionality. Clearly, this kind of knowledge is
needed to unravel the roles of CCCs in brain development, plas-
ticity, and disease.
While research on the diverse functions on CCCs in the CNS is
still in its infancy, the overall picture is exciting and holds promise
for major breakthroughs in our understanding of the most funda-
mental mechanisms underlying the workings of the nervous
system. The wide and rapidly increasing research investments
employing a wide spectrum of powerful molecular, electrophys-
iological, and imaging techniques is likely to lead to a fast nar-
rowing of the gap between the level of our knowledge of ion
transporters and ion channels.
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